Publications

Publicatons Since 2000

  • Latov N. Prognosis of Neuropathy with Monoclonal Gammopathy, Editorial, Muscle & Nerve 23: 150-152, 2000.
  • Latov N. Neuropathy, Heredity, and Monoclonal Gammopathy. Editorial, Arch Neurol 2000; 57: 641-42.
  • Latov N, Chaudhry V, Koski CL, Lisak RP, Apatoff BR, Hahn AF, Howard JF Jr. Use of intravenous gammaglobulins in neuroimmunologic diseases. J Allergy Clin Immunol 2001; 108: S126-32.
  • Latov N. Ed: Advances in the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy and related immune mediated neuropathies. Neurology 2002; 59 (suppl 6): S1-45.
  • Latov N. Diagnosis of CIDP. Neurology 2002; 59(suppl 6): S2-S6.
  • Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology 2003; 60: S8-15.
  • Chin RL, Sander HW, Brannagan TH, Green PH, Hays AP, Alaedini A, Latov N. Celiac Neuropathy, Neurology 2003; 60: 1581-5.
  • Sander HW, Magda P, Chin R, Wu A, Brannagan TH, Green PHR, Latov N. Cerebellar ataxia and celiac disease. Lancet 2003; 362: 1548.
  • Magda P, Latov N, Brannagan TH, Chin R, Sander H Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Arch Neurol 2003; 60: 1755-1759.
  • Lee G, Wirguin I, Willison HJ, Latov N. Expression of human anti-GM1 ganglioside antibodies in GM1-antibody transgenic mice. J Neuroimmunology, J Neuroimmunology 2004; 146:63-75.
  • Chin R, Latov N. Hays AP, Croul S, Magda P, Sander H, Brannagan
  • Chronic inflammatory demyelinating polyneuropathy (CIDP)presenting as cryptogenic sensory polyneuropathy. J Periph Nerv Syst 2004; 9: 132-7.
  • Latov N, Wu A, Chin RL, Sander HW, Alaedini A, Brannagan TH. Neuropathy and cognitive impairment following vaccination with the OspA protein of Borrelia Bergdorferi. J Periph Nerv Syst 2004; 9: 165-7.
  • Renaud S, Hays AP, Brannagan TH, Sander HH, Edgar M, Weimer LH, Olarte MR, Dalakas MC, Xiang Z, Danon MJ, Latov N. Gene expression profiling in Chronic Inflammatory Demyelinating Polyneuropathy. J Neuroimmunol 2005; 15;: 203-14.
  • Goldfarb AR, Sander HW, Brannagan TH, Magda P, Latov N. Characteirzation neuropathies associated with elevated IgM serum levels. J Neurol Sci 2005; 228:155-160.
  • Alaedini A, Latov N. Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue. J Neuroimmunol 2005; 159: 192-5.
  • Gondim FAA, Brannagan TH,Sander HW, Chin RL, Latov N. Peripheral neuropathy in patients with inflammatory bowel disease. Brain 2005; 128: 867-879.
  • England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, Cohen JA, Fisher MA, Howard JF, Kinsella LJ, Latov N, Lewis RA, Low PA, Sumner AJ. American Academy of Neurology, Distal symmetric polyneuropathy: a difinition for clinical research. Neurology, 2005; 64: 199-207.
  • Brannagan TH, Hays AP, Chin SS, Sander HW, Chin RL, Magda P,Green P, Latov N. Small fiber neuropathy associated with celiac disease: skin biopsy findings. Arch Neurol 2005; 62: 1574-8.
  • Green PH, Alaedini A, Sander HW, Brannagan TH, Latov N, Chin RL. Mechanisms underlying celiac disease and its neurologic manifestations. Cell Mol Life Sci. 2005; 62: 791-9.
  • Chin RL, Latov N. Central nervous system manifestations of rheumatological diseases. Curr Opin Rheumatology 2005; 17: 91-9.
  • Latov N, Gorson K, Brannagan TH. Diagnosis and Treatment of Chronic Immune Mediated Neuropathies. Clin Neuromusc Dis 2006; 7: 141-157.
  • Latov N. Peripheral Neuropathy: When the numbness, weakness and pain won’t stop.(American Academy of Neurology). Demos Medical Publications, NY, 2006.
  • Alaedini A, Latov N. Transglutaminase independent binding of gliadin to intestinal brush border memberane and GM1 ganglioside. J Neuroimmunol 2006; 177: 167-72.
  • Chin RL, Tseng VG, Green PH, Sander HW, Brannagan TH, Latov N. Multifocal axonal neuropathy in celiac disease. Neurology 2006; 66: 1923-5.
  • Goldfarb AR, Latov N, Brannagan TH, Chin RL, de Sousa EA, Sander HW. Correlation of clinical and demyelinating features in patients with neuropathy of otherwise unknown etiology. Neurol Neurophysiol Neuroscience 2006; Dec 22;:7.
  • Gondim FA, de Sousa EA, Latov N, Sander HW, Chin RL, Brannagan TH. Anti-MAG/SGPG associated neuropathy does not commonly cause distal nerve temporal dispersion.J Neurol Neurosurg Psychiat 2007; 78:902-4
  • Alaedini A, Okamoto H, Briani C, Wollenberg K, Shill HA, Bushara KO, Sander HW, Green PH, Hallett M, Latov N. Immune cross reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I. J Immunol 2007; 178: 6590-5.
  • Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Latov N, Merkies IS, van Doorn PA; ICE study group. Intravenous immune globulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomized placebo controlled trial. Lancet Neurol 2008; 7: 136-44.
  • Alaedini A, Xiang Z,Kim H, Sung YJ, Latov N. Up-regulation of apoptosis and regeneration genes in the dorsal root ganglia during cisplatin treatment. Exp Neurol 2008; 210:368-74.
  • Effect of intravenous immunoglobulin on cerebellar ataxia and neuropathic pain associated with celiac disease. Eur Neurol 2008; 15: 1300-3.
  • England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF Jr, Lauria G, Miller RG, Polydefkis M, Sumner AJ. Practice parameter: 1. evaluation of distal symmetric polyneuropathy: 1. role of laboratory and genetic testing, 2. Role of autonomic testing, nerve biopsy, and skin biopsy. (an evidence based review). Report of the American Academy of Neurology, American Association of Neuromuscular Medicine, and American Academy of Physical Medicine and Rehabilitation. Muscle Nerve 2009; 39:106-115,116-25. Neurology 2009; 72: 177-184, 185-92.
  • Bril V, Katzenberg H, Donofrio P, Banach M, Dalakas MC, Deng C, Hanna K, hartung HP, Hughes RA, Latov N, Merkies IS, van Doorn PA; ICE study group. Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV. Muscle Nerve 2009; 39: 448-55.
  • Merkies IS, Bril V, Dalakas MC, Deng C, Donofrio P, Hanna K, Hartung HP, Hughes RA, Latov N, van Doorn PA; ICE Study Group. Health related quality of life improvements in CIDP with immune globulin IV 10%; The Ice Study. Neurology 2009; 72: 1337-44.
  • De Sousa EA, Chin RL, Sander HW, Latov N, Brannagan TH 3rd. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy; sensitivity and specificity. J Clin Neuromusc Dis 2009; 10: 163-9.
  • Lee G, Xiang Z, Brannagan TH, Chin RL, Latov N. Differential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies. J Neurol Sci 2010; 290: 115-22.
  • Donofrio PD, Berger A, Brannagan TH, Bromberg MB, Howard JF, Latov N, quick A, Tandan R. Consensus statemen: the use of intravenous immunoglobulins in the treatment of neuromuscular conditions. Report of the AANEM Ad Hoc committee. Muscle Nerve 2009; 40: 890-900.
  • Latov N, Deng C, Dalakas M, Bril V, Donofrio, Hanna K, Hartung HP, Hughes RAC, Merkies ISJ, van Doorn P. Timing and course of clinical response to intravenous gammaglobulins in chronic inflammatory demyelinating polyradiculoneuropathy. Archives Neurol,2010, 67:802-7.
  • Chandra A, Wormser GP, Klempner MS, Trevino RP, Crow MK, Latov N, Alaedini A. Anti-neural antibody reactivity in patients with a history of Lyme boreliosis and persistent symptoms. Brain Behav Immun 2010; 24: 1018-24.
  • Chin RL, Sander HW, Brannagan TH, DeSousa E, Latov N. Demyelinating neuropathy in patients with hepatitis C virus infection. J Clin Neuromusc Dis 2010; 11: 209-12.
  • Kinter J, Broglio L, Steck AJ, Tonay M, Fuhr P, Latov N, Kalbermatten D, Sinnreich M, Schaeren-Wiemers N, Renaud S. Gene expression profiling in nerve biopsy of vasculitic neuropathy. J Neuroimmunol 2010; 225: 184-9.
  • Kinter J, Broglio L, Steck AJ, Tolnay M, Fuhr P, Latov N, Kalbermatten D, Sinnreich M, Schaeren-Wiemers N, Renaud S. Gene expression profiling I nerve biopsy fo vasculitic neuropathy. J Neuroimmunol 2010; 225: 184-9.
  • Chandra A, Wormsner GP, Marques AR, latov N, Alaedini A. Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome. Clin Vaccine Immunol 2011; 18: 767-71.
  • Chandra A, Latov N, Wormser GP, Marques AR, Alaedini A. Epitope mapping of antibodies to VISE protein of Borrelia burgdorferi in post-Lyme disease syndrome. Clin Immunol 2011; 141: 103-10.
  • Latov N, Dalakas M, Vallat JM, Donofrio P, Hartung HP, Toyka KV. Biomarkers in the diagnosis and therapy of CIDP; proceeds of the Biomarkers Faculty Meeting: June 8-9, Athens, Greece. J Peripher Nerv Syst 2011; 16 (suppl1): 1-2.
  • Latov N. Biomarkers of CIDP in patients with diabetes or CMT1. J Peripher Nerv Syst 2011; 16 (suppl 1:) 14-7.
  • Nodera H, Latov N, Carey B, Langsdrof J, Bedoya V, Tacheva S, Chin RL. Prolongation of the tibialis anterior CMAP duration in chronic inflammatory demyelinating polyneuropathy. Clin Neurophys 2012; 123: 393-8.
  • Vanhoutte EK, Latov N, Deng C,Hanna K, Hughes RA, Bril V, Dalakas MC, Donofrio P, van Doorn PA, Hartung HP, Merkies IS. Vigorometer grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG – the ICE study. Eur J Neurol 2013; 20: 748-55.
  • Latov N. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Nature Reviews Neurology 2014; 10: 435-446.
  • Vo ML, Latov N. Unreliability of commercial anti-MAG antibody and ganglioside assays. (letter) Muscle Nerve 2015; 51: 458-9.
  • Latov N, Chin RL, Vo ML. Maintenance therapy in chronic inflammatory demyelinating polyradiculoneuropathy. (letter) Muscle Nerve 2015; 52:915
  • Vo ML, Hanineva A, Chin RL, Carey BT, Latov N, Langsdorf JA. Comparison of 2-limb versus 3-limb electrodiagnostic studies in the evaluation of CIDP. Muscle Nerve 2015; 52: 549-53.
  • Latov N, Kumar G,Vo ML, Chin RL, Carey BT, Langsdorf JA, Feuer NT. Elevated blood mercury levels in idiopathic axonal neuropathy. JAMA Neurol 2015; 72: 474-5.
  • Vo ML, Martin P, Latov N. Correlation of changes in gait parameters with phenotype, outcome measures, and electrodiagnostic abnormalities in a patient with anti-MAG neuropathy after exacerbation and improvement. J Clin Neuromusc Dis 2015; 17: 22-6.
  • Chin RL,Deng C,Bril V,Hartung HP, Merkies IS, Donofrio PD, van Doorn PA, Dalakas MC, Latov N. Follow up nerve conduction studies in CIDP after treatment with IGIV-C: comparison of patients with and without subsequent relapse. Muscle Nerve 2015;52: 498-502.
  • Latov N, Vo ML, Chin RL, Carey BT, Langsdorf JA, Feuer NT. Abnormal nutritional factors in patients evaluated at a neuropathy Center. J Clin Neuromuscular Dis 2016; 17: 212-4.

Contact Us Now

How can we help you?

Send My Info

Your Peripheral Neuropathy Experts

  • Cutting-Edge Research
  • Renowned Team of Physicians
  • Fully Accredited by the AANEM
  • Treatments for a Variety of Nerve Problems
  • Comprehensive, Personalized Care for Each Patient
  • Comprehensive Diagnostic, Therapeutic & Consultative Services
  • Recognized as a Center of Excellence by The Neuropathy Association